134 related articles for article (PubMed ID: 33021845)
21. Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries.
Siangjong L; Goldman DH; Kriska T; Gauthier KM; Smyth EM; Puli N; Kumar G; Falck JR; Campbell WB
Acta Physiol (Oxf); 2017 Jan; 219(1):188-201. PubMed ID: 26666460
[TBL] [Abstract][Full Text] [Related]
22. Hepoxilin A3 is metabolized into its omega-hydroxy metabolite by human neutrophils.
Pace-Asciak CR; Reynaud D; Rounova O; Demin P; Pivnitsky KK
Adv Exp Med Biol; 1999; 469():535-8. PubMed ID: 10667379
[No Abstract] [Full Text] [Related]
23. Hepoxilin A3 synthase.
Nigam S; Zafiriou MP
Biochem Biophys Res Commun; 2005 Dec; 338(1):161-8. PubMed ID: 16198304
[TBL] [Abstract][Full Text] [Related]
24. Hepoxilin A3 is oxidized by human neutrophils into its omega-hydroxy metabolite by an activity independent of LTB4 omega-hydroxylase.
Reynaud D; Rounova O; Demin PM; Pivnitsky KK; Pace-Asciak CR
Biochim Biophys Acta; 1997 Oct; 1348(3):287-98. PubMed ID: 9366245
[TBL] [Abstract][Full Text] [Related]
25. Endogenous hepoxilin A3, produced under short duration of high shear-stress, inhibits thrombin-induced aggregation in human platelets.
Margalit A; Granot Y
Biochim Biophys Acta; 1994 Feb; 1190(1):173-6. PubMed ID: 8110811
[TBL] [Abstract][Full Text] [Related]
26. Hepoxilin signaling in intact human neutrophils: biphasic elevation of intracellular calcium by unesterified hepoxilin A3.
Reynaud D; Demin PM; Sutherland M; Nigam S; Pace-Asciak CR
FEBS Lett; 1999 Mar; 446(2-3):236-8. PubMed ID: 10100848
[TBL] [Abstract][Full Text] [Related]
27. Hepoxilin A3 is the endogenous lipid mediator opposing hypotonic swelling of intact human platelets.
Margalit A; Sofer Y; Grossman S; Reynaud D; Pace-Asciak CR; Livne AA
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2589-92. PubMed ID: 8464865
[TBL] [Abstract][Full Text] [Related]
28. Hepoxilin A3 blocks the release of norepinephrine from rat hippocampal slices.
Pace-Asciak CR; Wong L; Corey EJ
Biochem Biophys Res Commun; 1990 Dec; 173(3):949-53. PubMed ID: 2268355
[TBL] [Abstract][Full Text] [Related]
29. Hepoxilin A3 increases vascular permeability in the rat skin.
Laneuville O; Corey EJ; Couture R; Pace-Asciak CR
Eicosanoids; 1991; 4(2):95-7. PubMed ID: 1910867
[TBL] [Abstract][Full Text] [Related]
30. A lipoxygenase product, hepoxilin A(3), enhances nerve growth factor-dependent neurite regeneration post-axotomy in rat superior cervical ganglion neurons in vitro.
Amer RK; Pace-Asciak CR; Mills LR
Neuroscience; 2003; 116(4):935-46. PubMed ID: 12617935
[TBL] [Abstract][Full Text] [Related]
31. Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia.
Mrsny RJ; Gewirtz AT; Siccardi D; Savidge T; Hurley BP; Madara JL; McCormick BA
Proc Natl Acad Sci U S A; 2004 May; 101(19):7421-6. PubMed ID: 15123795
[TBL] [Abstract][Full Text] [Related]
32. The hepoxilins and some analogues: a review of their biology.
Pace-Asciak CR
Br J Pharmacol; 2009 Oct; 158(4):972-81. PubMed ID: 19422397
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-Derived Cytosolic PLA2α Contributes to Bacterial-Induced Neutrophil Transepithelial Migration.
Yonker LM; Pazos MA; Lanter BB; Mou H; Chu KK; Eaton AD; Bonventre JV; Tearney GJ; Rajagopal J; Hurley BP
J Immunol; 2017 Oct; 199(8):2873-2884. PubMed ID: 28887431
[TBL] [Abstract][Full Text] [Related]
34. Coupling of hepoxilin A3-specific binding with calcium-mobilizing actions in human neutrophils.
Reynaud D; Demin PM; Pace-Asciak CR
Agents Actions Suppl; 1995; 45():291-6. PubMed ID: 7717192
[No Abstract] [Full Text] [Related]
35. [A comparison of the effects of 5-hydroxyeicosatetraenoic acid and hepoxilin A3 on the plasticity of the snail neuronal cholinoreceptors].
Pivovarov AS; Demin PM; Miagkova GI
Biull Eksp Biol Med; 1993 Oct; 116(10):378-81. PubMed ID: 8117956
[TBL] [Abstract][Full Text] [Related]
36. Formation and metabolism of hepoxilin A3 by the rat brain.
Pace-Asciak CR
Biochem Biophys Res Commun; 1988 Feb; 151(1):493-8. PubMed ID: 3348791
[TBL] [Abstract][Full Text] [Related]
37. Bioconversion of arachidonic acid into human 14,15-hepoxilin B
Lee J; Kim TH; Oh DK
Biotechnol Lett; 2020 Oct; 42(10):2001-2009. PubMed ID: 32488442
[TBL] [Abstract][Full Text] [Related]
38. Isozyme specificity in the conversion of hepoxilin A3 (HxA3) into a glutathionyl hepoxilin (HxA3-C) by the Yb2 subunit of rat liver glutathione S-transferase.
Laneuville O; Chang M; Reddy CC; Corey EJ; Pace-Asciak CR
J Biol Chem; 1990 Dec; 265(35):21415-8. PubMed ID: 2254303
[TBL] [Abstract][Full Text] [Related]
39. Epoxide hydratase assay in human platelets using hepoxilin A3 as a lipid substrate.
Pace-Asciak CR; Klein J; Speilberg SP
Biochim Biophys Acta; 1986 Feb; 875(2):406-9. PubMed ID: 3942774
[TBL] [Abstract][Full Text] [Related]
40. The rat leukocyte-type 12-lipoxygenase exhibits an intrinsic hepoxilin A3 synthase activity.
Nigam S; Patabhiraman S; Ciccoli R; Ishdorj G; Schwarz K; Petrucev B; Kühn H; Haeggström JZ
J Biol Chem; 2004 Jul; 279(28):29023-30. PubMed ID: 15123652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
